Toxic Effect of Fullerene and Its Derivatives upon the Transmembrane β2-Adrenergic Receptors

Numerous experiments have revealed that fullerene (C-60) and its derivatives can bind to proteins and affect their biological functions. In this study, we explored the interaction between fullerine and the beta 2 -adrenergic receptor (beta(2)AR). The MD simulation results show that fullerene binds with the extracellular loop 2 (ECL2) and intracellular loop 2 (ICL2) of beta(2)AR through hydrophobic interactions and pi-pi stacking interactions. In the C-60_in1 trajectory, due to the pi-pi stacking interactions of fullerene molecules with PHE and PRO residues on ICL2, ICL2 completely flipped towards the fullerene direction and the fullerene moved slowly into the lipid membrane. When five fullerene molecules were placed on the extracellular side, they preferred to stack into a stable fullerene cluster (a deformed tetrahedral aggregate), and had almost no effect on the structure of beta(2)AR. The hydroxyl groups of fullerene derivatives (C-60(OH)(X), X represents the number of hydroxyl groups, X = 4, 8) can form strong hydrogen bonds with the ECL2, helix6, and helix7 of beta(2)AR. The hydroxyl groups firmly grasp the beta(2)AR receptor like several claws, blocking the binding entry of ligands. The simulation results show that fullerene and fullerene derivatives may have a significant effect on the local structure of beta(2)AR, especially the distortion of helix4, but bring about no great changes within the overall structure. It was found that C-60 did not compete with ligands for binding sites, but blocked the ligands' entry into the pocket channel. All the above observations suggest that fullerene and its derivatives exhibit certain cytotoxicity.

Automated summary

Fullerene and its derivatives can bind to proteins and affect their biological functions. This study found that fullerene can interact with the beta 2 -adrenergic receptor through hydrophobic and pi-pi stacking interactions, and the hydroxyl groups of fullerene derivatives can firmly grasp the receptor, blocking ligand binding.